GSE147876 GSE147877 enzalutamide MR42D 4 v 10 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE147876_GSE147877_enzalutamide_MR42D_4_v_10_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE147876_GSE147877_enzalutamide_MR42D_4_v_10_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE147876_GSE147877_enzalutamide_MR42D_4_v_10_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE147876_GSE147877_enzalutamide_MR42D_4_v_10_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

ribosomal protein S4 Y-linked 1

Gene

eukaryotic translation initiation factor 1A Y-linked

Gene

lysine demethylase 5D

Gene

clusterin

Gene

inhibitor of DNA binding 1

Gene

carbonic anhydrase 12

Gene

ISG15 ubiquitin like modifier

Gene

fibroblast growth factor receptor 3

Gene

solute carrier family 38 member 1

Gene

tissue factor pathway inhibitor

  • Gene

    ribosomal protein S4 Y-linked 1


  • Gene

    eukaryotic translation initiation factor 1A Y-linked


  • Gene

    lysine demethylase 5D



  • Gene

    inhibitor of DNA binding 1


  • Gene

    carbonic anhydrase 12


  • Gene

    ISG15 ubiquitin like modifier


  • Gene

    fibroblast growth factor receptor 3


  • Gene

    solute carrier family 38 member 1


  • Gene

    tissue factor pathway inhibitor

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.